Diabetic Medicine

Diabetes and driving
pp. 617-618(2)
Author: Mansell P.

Neuropeptides and appetite control
pp. 619-627(9)
Author: Wilding J.P.H.

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life
pp. 628-634(7)
Authors: Bruttomesso D.; Pianta A.; Crazzolara D.; Scaldaferri E.; Lora L.; Guarneri G.; Mongillo A.; Gennaro R.; Miola M.; Moretti M.; Confortin L.; Beltramello G.P.; Pais M.; Baritussio A.; Casiglia E.; Tiengo A.

Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes
pp. 635-642(8)
Authors: Anderson B.J.; Vangsness L.; Connell A.; Butler D.; Goebel-Fabbri A.; Laffel L.M.B.

A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with Type 1 diabetes
pp. 643-648(6)
Authors: Howells L.; Wilson A.C.; Skinner T.C.; Newton R.; Morris A.D.; Greene S.A.

Current methods of transfer of young people with Type 1 diabetes to adult services
pp. 649-654(6)
Authors: Kipps S.; Bahu T.; Ong K.; Ackland F.M.; Brown R.S.; Fox C.T.; Griffin N.K.; Knight A.H.; Mann N.P.; Neil H.A.W.; Simpson H.; Edge J.A.; Dunger D.B.

Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy
pp. 655-660(6)
Authors: Hernández C.; Lecube A.; Segura R.M.; Sararols L.; Simó R.

Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies
pp. 661-666(6)
Authors: Bril V.; Perkins B.A.

Space–time clustering of childhood Type 1 diabetes in Devon and Cornwall, England
pp. 667-672(6)
Authors: Zhao H.X.; Moyeed R.A.; Stenhouse E.A.; Demaine A.G.; Millward B.A.

Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance^®) in Type 2 diabetic patients inadequately controlled on metformin
pp. 673-680(8)
Authors: Marre M.; Howlett H.; Lehert P.; Allavoine T.

The prevalence of the mitochondrial DNA 16189 variant in non-diabetic Korean adults and its association with higher fasting glucose and body mass index
pp. 681-684(4)
Authors: Kim J.H.; Park K.S.; Cho Y.M.; Kang B.S.; Kim S.K.; Jeon H.J.; Kim S.Y.; Lee H.K.

Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes
pp. 685-688(4)
Authors: Evans J.M.M.; Donnan P.T.; Morris A.D.

A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women
pp. 689-692(4)
Authors: Pannacciulli N.; De Pergola G.; Giorgino F.; Giorgino R.

Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease
pp. 693-696(4)
Authors: Oyibo S.O.; Pritchard G.M.; Mclay L.; James E.; Laing I.; Gokal R.; Boulton A.J.M.

Reduced prevalence of late-diabetic complications in MODY3 with early diagnosis
pp. 697-698(2)
Authors: Sagen J.V.; Njølstad P.R.; Søvik O.

Blood glucose measurement in acute medicine: inadequate detection and management
pp. 698-698(1)
Authors: Hennessy A.-R.; Reynolds R.M.; Walker J.D.

A case of euglycaemic diabetic ketoacidosis in pregnancy—a reply
pp. 699-699(1)
Authors: Deepak D.; Ingham D.; Reynolds R.M.; Walker J.D.

Poor glycaemic control in female Type 1 adolescents—the ‘fragile female diabetic’ revisited?
pp. 699-700(2)
Author: Gill G.

Author's reply
pp. 700-701(2)
Authors: Tuvemo T.; Gustafsson J.; Tylleskär K.

Feasibility and usefulness of dedicated software and e-mail for self-monitoring blood glucose in treating diabetes
pp. 701-702(2)
Authors: Perlemuter L.; Yomtov B.

Improving outcomes for young people with diabetes
pp. 702-703(2)
Author: Dorchy H.

The lost tribes in diabetes
pp. 703-703(1)
Authors: Kerr D.; Nicholls H.; Cavan D.A.

Lipids and Vascular Disease Current Issues
pp. 704-704(1)
Author: Scott A.

Diabetic Nephropathy
pp. 704-705(2)
Author: Wilkie M.

Diabetic Medicine diary
pp. 706-706(1)
Author: Etherington D.